The NAFLD-HCC Glycogene Risk Model (NHGRM) signature included the following genes: SPP1, SOCS2, SAPCD2, S100A9, RAMP3, and CSAD. The gene discussed is CSAD; the disease is metabolic dysfunction-associated steatotic liver disease.